Home > Healthcare > Pharmaceuticals > Finished Drug Form > Cytomegalovirus (CMV) Treatment Market

Cytomegalovirus (CMV) Treatment Market Share

Report ID: GMI8288
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

CMV Treatment Market Share

The competitive landscape of the cytomegalovirus treatment industry is characterized by the presence of established pharmaceutical companies vying for market share. Key players are engaging in strategic initiatives such as mergers, acquisitions, and partnerships to strengthen their product portfolios. The companies are actively adopting a multi-pronged approaches to address the rising demand for effective cytomegalovirus (CMV) treatment.

CMV Treatment Market Companies

Prominent players operating in the CMV treatment industry are as mentioned below:

Chimerix
Clinigen Group PLC
F. Hoffmann-La Roche Ltd
Fresenius Kabi
Genentech Inc.
Gilead Sciences, Inc.
Merck & Co. Inc
Mylan N.V
Pfizer, Inc.
Takeda Pharmaceuticals
Teva Pharmaceuticals Inc
Thermo Fisher Scientific Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Cytomegalovirus (CMV) treatment industry size reached USD 474.6 million in 2023 and is poised to expand at 6.6% CAGR from 2024-2032 propelled by increasing awareness and prevalence of CMV infection, as well as the development of new and effective treatments.

The ganciclovir drug type generated USD 162.5 million in revenue in 2023 and is estimated to record high demand by 2032 driven by the increasing number of solid organ and hematopoietic stem cell transplants globally.

North America CMV treatment market is set to exhibit robust growth between 2024 and 2032 owing to the increasing consumer awareness, growing incidences of cytomegalovirus infections, and the presence of key market players in the region.

Some of the major companies engaged in the CMV treatment industry are Chimerix, Clinigen Group PLC, F. Hoffmann-La Roche Ltd, Genentech Inc., Gilead Sciences, Inc., Merck & Co. Inc, Mylan N.V, Pfizer, Inc., Takeda Pharmaceuticals, Teva Pharmaceuticals Inc, and Thermo Fisher Scientific Inc.